CDNF Human Catalog number: B2018812 Lot number: Batch Dependent Expiration Date: Batch dependent Amount: 1 μg Molecular Weight or Concentration: ~18 kDa Supplied as: Powder Applications: a molecular tool for various biochemical applications Storage: -20°C Keywords: Cerebral dopamine neurotrophic factor, ARMET-like protein 1 Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. References Konovalova J, Gerasymchuk D, Arroyo SN, Kluske S, Mastroianni F, Pereyra AV, Domanskyi A. Human-Specific Regulation of Neurotrophic Factors MANF and CDNF by microRNAs Int J Mol Sci. 2021 Sep 7;22(18):9691. Pakarinen E, Lindholm P. CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease Front Psychiatry. 2023 Jul 24;14:1188697. Axelsen TM, Woldbye DPD. Gene Therapy for Parkinson’s Disease, An Update J Parkinsons Dis. 2018;8(2):195-215. Lõhelaid H, Saarma M, Airavaara M. CDNF and ER stress: Pharmacology and therapeutic possibilities Pharmacol Ther. 2024 Feb;254:108594. Lindahl M, Saarma M, Lindholm P. Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potential Neurobiol Dis. 2017 Jan;97(Pt B):90-102. Eremin DV, Ilchibaeva TV, Tsybko AS. Cerebral Dopamine Neurotrophic Factor (CDNF): Structure, Functions, and Therapeutic Potential Biochemistry (Mosc). 2021 Jul;86(7):852-866. Huttunen HJ, Saarma M. CDNF Protein Therapy in Parkinson’s Disease Cell Transplant. 2019 Apr;28(4):349-366. Jӓntti M, Harvey BK. Trophic activities of endoplasmic reticulum proteins CDNF and MANF Cell Tissue Res. 2020 Oct;382(1):83-100. Lindholm P, Saarma M. Novel CDNF/MANF family of neurotrophic factors Dev Neurobiol. 2010 Apr;70(5):360-71.
Related
Related
Related